Clinical Trial

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

Study acronym: CHRONOSTEATOSI
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to demonstrate that an \< or equal to 8-hour time-restricted eating (i.e., fasting for at least 16 hours every day), not focusing on reducing caloric intake, reduces intra-hepatic fat in patients with obesity and Metabolic dysfunction-Associated Steatotic liver Disease (MASLD).
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-30
notable Primary completion moved earlier: 2030-05 -> 2029-06 2026-06-30
minor Completion moved earlier: 2030-08 -> 2029-06 2026-06-30
Trial Details
NCT Number NCT07378072
Lead Sponsor Nantes University Hospital
Conditions MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Enrollment 72 participants
Start Date 2026-06-17
Primary Completion 2029-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-29